Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Rechercher des publications
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 460 du 11 septembre 2020
Qualité de vie, soins de support (2)
A partir d’une revue systématique de la littérature (16 études), cette étude analyse l’intérêt des technologies de e-santé pour aider les familles ayant un enfant atteint d’un cancer
The role of Connected Health technologies in supporting families affected by paediatric cancer: A Systematic Review
A partir d’une revue systématique de la littérature (16 études), cette étude analyse l’intérêt des technologies de e-santé pour aider les familles ayant un enfant atteint d’un cancer
The role of Connected Health technologies in supporting families affected by paediatric cancer: A Systematic Review
Emma Delemere, Rebecca Maguire
Objectives : Families impacted by paediatric cancer are met with logistical, financial and psychological impacts, with SARS?CoV?2 creating additional barriers and stressors for these families. Connected health (CH) may facilitate cancer care. The objective of the present study was to systematically review CH for families/informal caregivers affected by paediatric cancer. Methods : Using search terms relating to: (1) paediatric cancer, (2) family/caregivers, and (3) CH, the databases of [...]
A partir d’une revue systématique de la littérature (24 études), cette étude identifie et analyse l’efficacité des interventions à faible coût permettant d’atténuer une mucite buccale induite par la radiothérapie chez des patients atteints d’un cancer de la tête et du cou
A systematic review of interventions to mitigate radiotherapy-induced oral mucositis in head and neck cancer patients
A partir d’une revue systématique de la littérature (24 études), cette étude identifie et analyse l’efficacité des interventions à faible coût permettant d’atténuer une mucite buccale induite par la radiothérapie chez des patients atteints d’un cancer de la tête et du cou
A systematic review of interventions to mitigate radiotherapy-induced oral mucositis in head and neck cancer patients
Catrina Davy, Sharron Heathcote
Background : Oral mucositis is a debilitating consequence of radiotherapy in patients with head and neck cancers. Radiation-induced oral mucositis (RIOM) can cause pain and weight loss, reduce quality of life and affect treatment outcomes. Methods : A systematic review was undertaken to identify and examine the efficacy of low-cost interventions to mitigate RIOM and to develop clinical guidelines based on the evidence. Results : The author identified three interventions: benzydamine [...]
Observation (8)
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The Day After COVID-19—Time to Rethink Oncology Clinical Research
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
The Day After COVID-19—Time to Rethink Oncology Clinical Research
Daniel V. Araujo, Geoffrey A. Watson, Lillian L. Siu (et al.)
The declaration of the coronavirus disease 2019 (COVID-19) as a pandemic by the World Health Organization on March 11, 2020, has led to unprecedented measures such as social distancing and economic lockdown by many international governments to combat viral spread and to prevent health care systems from collapsing. Regardless of its ensuing course, the pandemic’s effect will undoubtedly linger in many aspects of cancer care and research, including oncology clinical trials.
Immunological features of coronavirus disease 2019 in patients with cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immunological features of coronavirus disease 2019 in patients with cancer
Marion Thibaudin, Jean-David Fumet, Marjorie Bon (et al.)
Background : Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has caused a major pandemic. Patients with cancer are at higher risk of severe COVID-19. We aimed to describe and compare the immunological features of cancer patients hospitalized for COVID-19 or other concomitant, cancer-related illness. Methods : In this prospective study, the clinical and immunological characteristics of 11 cancer patients with COVID-19 and 11 non-COVID-19 cancer [...]
An epidemiological modelling approach for COVID-19 via data assimilation
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
An epidemiological modelling approach for COVID-19 via data assimilation
Nadler, Philip ; Wang, Shuo ; Arcucci, Rossella ; Yang, Xian ; Guo, Yike
The global pandemic of the 2019-nCov requires the evaluation of policy interventions to mitigate future social and economic costs of quarantine measures worldwide. We propose an epidemiological model for forecasting and policy evaluation which incorporates new data in real-time through variational data assimilation. We analyze and discuss infection rates in the UK, US and Italy. We furthermore develop a custom compartmental SIR model fit to variables related to the available data of the [...]
Risk of death of cancer patients presenting with severe symptoms of infection, with or without documented COVID-19
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Risk of death of cancer patients presenting with severe symptoms of infection, with or without documented COVID-19
Souad Assaad, Christine Fuhrmann, Virginie Avrillon, Isabelle Ray-Coquard (et al.)
We would like to thank Dr van Dam and colleagues (1) for their letter and the careful attention they dedicated to our work (2).We want first to express our full agreement to their conclusion stating that cancer patients must « have maximal access to (adapted) treatment and if necessary maximal supportive care in times of SARS-CoV-2 pandemic ». Indeed, the COVID-19 epidemic is affecting deeply the care of patients with cancer for at least three reasons. The first one is the delay to treatment [...]
Rapid deployment of virtual mind-body interventions during the COVID-19 outbreak: feasibility, acceptability, and implications for future care
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Rapid deployment of virtual mind-body interventions during the COVID-19 outbreak: feasibility, acceptability, and implications for future care
Trevino, Kelly M. ; Raghunathan, Nirupa ; Latte-Naor, Shelly ; Polubriaginof, Fernanda C. G. ; Jensen, Claus ; Atkinson, Thomas M. ; Emard, Nicholas ; Seluzicki, Christina M. ; Ostroff, Jamie S. ; Mao, Jun J.
Introduction : COVID-19 increased stress levels while reducing access to mind-body services in patients with cancer. We describe the rapid deployment of remotely delivered mind-body services to people with cancer during COVID-19, rates of participation, and acceptability from patients’ perspectives. Methods : Eligible participants were patients with cancer age [...]
Menée à partir des données des registres américains des cancers portant sur 27 602 patientes atteintes d’un cancer épithélial de l’ovaire diagnostiqué entre 2000 et 2016, cette étude analyse les disparités ethniques dans le risque de second cancer gynécologique en lien avec les traitements anticancéreux
Risks of Second Primary Gynecologic Cancers Following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000–2016
Menée à partir des données des registres américains des cancers portant sur 27 602 patientes atteintes d’un cancer épithélial de l’ovaire diagnostiqué entre 2000 et 2016, cette étude analyse les disparités ethniques dans le risque de second cancer gynécologique en lien avec les traitements anticancéreux
Risks of Second Primary Gynecologic Cancers Following Ovarian Cancer Treatment in Asian Ethnic Subgroups in the United States, 2000–2016
Nita H. Mukand, Ashwini Zolekar, Naomi Y. Ko, Gregory S. Calip
Background: The differential occurrence of second primary cancers by race following ovarian cancer is poorly understood. Our objective was to determine the incidence of second primary gynecologic cancers (SPGC) following definitive therapy for ovarian cancer. Specifically, we aimed to determine differences in SPGC incidence by Asian ethnic subgroups. Methods: We identified 27,602 women ages 20 years and older and diagnosed with first primary epithelial ovarian cancer between 2000 and 2016 who [...]
Menée aux Etats-Unis, cette étude analyse les facteurs associés aux disparités ethniques dans le risque de cancer et la survie
Cancer health disparities in racial/ethnic minorities in the United States
Menée aux Etats-Unis, cette étude analyse les facteurs associés aux disparités ethniques dans le risque de cancer et la survie
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, Valentina A. ; Bracci, Paige M. ; Carethers, John M. ; Carvajal-Carmona, Luis ; Coggins, Nicole B. ; Cruz-Correa, Marcia R. ; Davis, Melissa ; De Smith, Adam J. ; Dutil, Julie ; Figueiredo, Jane C. ; Fox, Rena ; Graves, Kristi D. ; Gomez, Scarlett Lin ; Llera, Andrea ; Neuhausen, Susan L. ; Newman, Lisa ; Nguyen, Tung ; Palmer, Julie R. ; Palmer, Nynikka R. ; Perez-Stable, Eliseo J. ; Piawah, Sorbarikor ; Rodriquez, Erik J. ; Sanabria-Salas, María Carolina ; Schmit, Stephanie L. ; Serrano-Gómez, Silvia J. ; Stern, Mariana C. ; Weitzel, Jeffrey ; Yang, Jun J. ; Zabaleta, Jovanny ; Ziv, Elad ; Fejerman, Laura
There are well-established disparities in cancer incidence and outcomes by race/ethnicity that result from the interplay between structural, socioeconomic, socio-environmental, behavioural and biological factors. However, large research studies designed to investigate factors contributing to cancer aetiology and progression have mainly focused on populations of European origin. The limitations in clinicopathological and genetic data, as well as the reduced availability of biospecimens from [...]
Menée aux Etats-Unis à partir de données portant sur 1 207 patients ayant survécu à une leucémie lymphoblastique aiguë (âge moyen : 30,6 ans) et sur 2 273 témoins, cette étude analyse l’association entre la chimiothérapie, l’état des fonctions physiques et la présence de déficiences neurocognitives selon le sexe
Sex-specific associations between chemotherapy, chronic conditions and neurocognitive impairment in ALL survivors: A report from the Childhood Canc...
Menée aux Etats-Unis à partir de données portant sur 1 207 patients ayant survécu à une leucémie lymphoblastique aiguë (âge moyen : 30,6 ans) et sur 2 273 témoins, cette étude analyse l’association entre la chimiothérapie, l’état des fonctions physiques et la présence de déficiences neurocognitives selon le sexe
Sex-specific associations between chemotherapy, chronic conditions and neurocognitive impairment in ALL survivors: A report from the Childhood Cancer Survivor Study
Ellen van der Plas, Weiyu Qiu, Brian J Nieman, Yutaka Yasui (et al.)
Background : The purpose was to examine associations between treatment and chronic health conditions with neurocognitive impairment survivors of acute lymphoblastic leukemia (ALL) treated with chemotherapy only. Methods : This cross-sectional study included 1,207 ALL survivors (54.0% female; mean age 30.6 years) and 2,273 siblings (56.9% female; mean age 47.6 years), who completed the CCSS Neurocognitive Questionnaire. Multivariable logistic regression compared prevalence of neurocognitive [...]
Menée aux Etats-Unis à partir de données portant sur 8 259 adolescents et jeunes adultes ayant survécu au moins 2 ans à un mélanome cutané diagnostiqué entre 1996 et 2012 (âge : 15-39 ans), cette étude analyse les facteurs, notamment ethniques et socioéconomiques, associés à la survenue d’effets indésirables tardifs liés aux traitements anticancéreux
Disparities in the Occurrence of Late Effects Following Treatment among Adolescent and Young Adult Melanoma Survivors
Menée aux Etats-Unis à partir de données portant sur 8 259 adolescents et jeunes adultes ayant survécu au moins 2 ans à un mélanome cutané diagnostiqué entre 1996 et 2012 (âge : 15-39 ans), cette étude analyse les facteurs, notamment ethniques et socioéconomiques, associés à la survenue d’effets indésirables tardifs liés aux traitements anticancéreux
Disparities in the Occurrence of Late Effects Following Treatment among Adolescent and Young Adult Melanoma Survivors
Alicia A. Gingrich, Candice A.M. Sauder, Melanie Goldfarb (et al.)
Background: Melanoma is the third most common cancer in the adolescent and young adult (AYA) population; however, no studies have addressed the occurrence of adverse health conditions following melanoma treatment in these survivors. Methods: Data for patients ages 15 to 39 years diagnosed with cutaneous melanoma from 1996 to 2012 and surviving ?2 years were obtained from the California Cancer Registry and linked to statewide hospitalization data. The influence of age at diagnosis, sex, [...]
Menée en Norvège à partir de données portant sur 244 hommes atteints d’un adénocarcinome de l’œsophage, cette étude analyse l’association entre le niveau d’hormones sexuelles mesuré avant le diagnostic et la survie
Pre-diagnostic Circulating Levels of Sex Hormones and Survival in Esophageal Adenocarcinoma
Menée en Norvège à partir de données portant sur 244 hommes atteints d’un adénocarcinome de l’œsophage, cette étude analyse l’association entre le niveau d’hormones sexuelles mesuré avant le diagnostic et la survie
Pre-diagnostic Circulating Levels of Sex Hormones and Survival in Esophageal Adenocarcinoma
Shao Hua Xie, Eivind Ness Jensen, Hilde Langseth (et al.)
Sex hormonal differences may contribute to the strong male predominance in esophageal adenocarcinoma (EAC), but whether sex hormone levels influence survival in EAC is unstudied. This study aimed to assess associations between pre?diagnostic sex hormone levels and survival in EAC. In population?based cohort study, 244 male EAC patients from the Janus Serum Bank Cohort in Norway were followed up through 2018. Associations between pre?diagnostic serum levels of 12 sex hormone measures and [...]
Menée aux Etats-Unis à partir de données portant sur 526 690 patients atteints d'un cancer de la prostate traité par prostatectomie radicale entre 2004 et 2014, cette étude analyse les disparités ethniques dans la survie globale et la mortalité
Racial disparities in mortality for patients with prostate cancer after radical prostatectomy
Menée aux Etats-Unis à partir de données portant sur 526 690 patients atteints d'un cancer de la prostate traité par prostatectomie radicale entre 2004 et 2014, cette étude analyse les disparités ethniques dans la survie globale et la mortalité
Racial disparities in mortality for patients with prostate cancer after radical prostatectomy
Wen, Wanqing ; Luckenbaugh, Amy N. ; Bayley, Christina E. ; Pension, David F. ; Shu, Xiao-Ou
Background : Although racial disparities in prostate cancer survival are well documented, the relative importance of contributing factors remains unclear. Few studies have examined the disparity between Whites and Hispanics or between Whites and Asian Americans and Pacific Islanders (AAPIs). Methods : Using data from the National Cancer Database for 526,690 patients with prostate cancer who underwent radical prostatectomy between 2004 and 2014, this study systematically evaluated the impact of [...]
Menée aux Etats-Unis à partir de données portant sur 329 adultes ayant survécu à une tumeur cérébrale pendant l’enfance, cette étude analyse la présence de troubles de l'équilibre et les déficiences physiques associées
Balance impairment in survivors of pediatric brain cancers: risk factors and associated physical limitations
Menée aux Etats-Unis à partir de données portant sur 329 adultes ayant survécu à une tumeur cérébrale pendant l’enfance, cette étude analyse la présence de troubles de l'équilibre et les déficiences physiques associées
Balance impairment in survivors of pediatric brain cancers: risk factors and associated physical limitations
Mitra Varedi, Lu Lu, Nicholas S. Phillips (et al.)
Purpose : The study aims were to determine the prevalence of balance impairments in adult survivors of pediatric central nervous system (CNS) tumors, and to identify predictors of and limitations associated with balance impairments. Methods : Participants were adult survivors (N?=?329) of pediatric CNS tumors. Balance was considered impaired among those with composite scores 70 on the sensory organization test. Potential predictors of impaired balance were evaluated with generalized linear [...]
Approches psycho-sociales (1)
A partir d’une revue systématique de la littérature publiée de 1994 à 2020 (16 études), cette étude fait le point sur les difficultés psychologiques des patients atteints d’un cancer, défigurés par la maladie et stigmatisés
Stigma in the face of cancer disfigurement: A systematic review and research agenda
A partir d’une revue systématique de la littérature publiée de 1994 à 2020 (16 études), cette étude fait le point sur les difficultés psychologiques des patients atteints d’un cancer, défigurés par la maladie et stigmatisés
Stigma in the face of cancer disfigurement: A systematic review and research agenda
Lisa M. Reynolds, Lauren Harris
Introduction : An emerging body of work has reported on the psychological impact of disfigurement on cancer patients; however, the extent of research focusing on stigmatisation in this context is unclear. This review aimed to evaluate how stigma associated with disfigurement impacts on cancer patients. Methods : A systematic review of literature was conducted using SCOPUS, Web of Science, MEDLINE and PubMed databases. Articles were included if they described a qualitative or quantitative study [...]
Analyses économiques et systèmes de soins (2)
Menée en France dans la région Rhône-Alpes à partir de données portant sur 271 patientes atteintes d’un cancer épithélial de l’ovaire, cette étude analyse l’effet, sur l’organisation des soins dans le contexte des traitements de première ligne, d’une prise en charge par un comité de concertation pluridisciplinaire
Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes...
Menée en France dans la région Rhône-Alpes à partir de données portant sur 271 patientes atteintes d’un cancer épithélial de l’ovaire, cette étude analyse l’effet, sur l’organisation des soins dans le contexte des traitements de première ligne, d’une prise en charge par un comité de concertation pluridisciplinaire
Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first-line setting. Exhaustive analysis from the Rhone-Alpes region
Domenico Ferraioli, Olivia Bally, Pierre Meeus, David Benayoun (et al.)
Objective : Epithelial ovarian cancer (EOC) is a poor prognosis disease partly linked to diagnosis at an advanced stage. The quality of care management is a factor that needs to be explored, more specifically optimal organisation of first?line treatment. Methods : A retrospective study, dealing with all patients diagnosed within the Rhone?Alpes region with initial diagnosis EOC in 2012, was performed. The aim was to describe the impact of multidisciplinary tumour boards (MTB) in the [...]
Menée aux Etats-Unis par enquête auprès de patientes atteintes d'un cancer du sein diagnostiqué entre 18 et 39 ans (830 répondantes), cette étude analyse l'impact des coûts liés aux traitements sur l'accès aux soins
Treatment cost and access to care: experiences of young women diagnosed with breast cancer
Menée aux Etats-Unis par enquête auprès de patientes atteintes d'un cancer du sein diagnostiqué entre 18 et 39 ans (830 répondantes), cette étude analyse l'impact des coûts liés aux traitements sur l'accès aux soins
Treatment cost and access to care: experiences of young women diagnosed with breast cancer
Subramanian, Sujha ; Tangka, Florence K. L. ; Edwards, Patrick ; Jones, Madeleine ; Flanigan, Tim ; Kaganova, Jenya ; Smith, Kevin ; Thomas, Cheryll C. ; Hawkins, Nikki A. ; Rodriguez, Juan L. ; Guy, Gery P. ; Fairley, Temeika
Purpose : Breast cancer is the leading cause of cancer-related deaths in women younger than 40 years. We aim to evaluate cost as a barrier to care among female breast cancer patients diagnosed between 18 to 39 years. Methods : In early 2017, we distributed a survey to women diagnosed with breast cancer between the ages of 18 and 39 years, as identified by the central cancer registries of California, Georgia, North Carolina, and Florida. We used multivariable statistics to explore cost-related [...]